MIR3163

Across TCGA pan-cancer cohorts, MIR3163 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR3163 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR3163 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3163 expression acts as an unfavorable survival marker, although some lineages such as PAAD and OV show a favorable association.

ACC, MESO, and UCEC are the cancer types where MIR3163 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.082	0.502	<.001	99	view →
MESO	OS	Tertile	III,IV	0.044	0.610	<.001	72	view →
UCEC	OS	Tertile	All	0.862	0.931	.003	36	view →
LIHC	DFS	Tertile	II,III,IV	0.140	0.436	.001	36	view →
PAAD	OS	Tertile	All	1.000	0.357	.004	27	view →
THCA	DFS	Tertile	IV	0.328	0.828	.024	15	view →
PRAD	OS	Tertile	All	0.966	0.997	.008	12	view →
LAML	DFS	Quartile	All	0.415	0.629	.025	10	view →
SARC	DFS	Tertile	All	0.374	0.637	.024	9	view →
OV	DFS	Tertile	III,IV	0.286	0.146	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR3163–ACC (DFS)

Open the ACC breakdown →